Evasion of neutralising antibodies by omicron sublineage BA.2.75
- PMID: 36058228
- PMCID: PMC9436366
- DOI: 10.1016/S1473-3099(22)00524-2
Evasion of neutralising antibodies by omicron sublineage BA.2.75
Conflict of interest statement
STR is a cofounder of, and held shares in, deepCDR Biologics, which has been acquired by Alloy Therapeutics. DJS, GBKH, and BM have intellectual property rights associated with antibodies that neutralise omicron variants. All other authors declare no competing interests.
Figures

References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources